CN102670893B - Traditional Chinese medicine composition for treating atherosclerosis - Google Patents
Traditional Chinese medicine composition for treating atherosclerosis Download PDFInfo
- Publication number
- CN102670893B CN102670893B CN 201210175181 CN201210175181A CN102670893B CN 102670893 B CN102670893 B CN 102670893B CN 201210175181 CN201210175181 CN 201210175181 CN 201210175181 A CN201210175181 A CN 201210175181A CN 102670893 B CN102670893 B CN 102670893B
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- traditional chinese
- treating atherosclerosis
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 34
- 239000000203 mixture Substances 0.000 title claims description 8
- 201000001320 Atherosclerosis Diseases 0.000 title abstract description 5
- 229940079593 drug Drugs 0.000 claims abstract description 9
- 241000628997 Flos Species 0.000 claims abstract description 7
- 239000009636 Huang Qi Substances 0.000 claims abstract description 7
- 230000003143 atherosclerotic effect Effects 0.000 claims description 12
- 241000237636 Pheretima Species 0.000 claims description 7
- 210000000582 semen Anatomy 0.000 claims description 5
- 230000000694 effects Effects 0.000 abstract description 6
- 239000008280 blood Substances 0.000 abstract description 5
- 210000004369 blood Anatomy 0.000 abstract description 5
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241000361919 Metaphire sieboldi Species 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- 239000012141 concentrate Substances 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 102000015427 Angiotensins Human genes 0.000 description 1
- 108010064733 Angiotensins Proteins 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 206010048010 Withdrawal syndrome Diseases 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000003405 delayed action preparation Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000010247 heart contraction Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- GLBJJMFZWDBELO-UHFFFAOYSA-N pimobendane Chemical compound C1=CC(OC)=CC=C1C1=NC2=CC=C(C=3C(CC(=O)NN=3)C)C=C2N1 GLBJJMFZWDBELO-UHFFFAOYSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000002537 thrombolytic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine for treating atherosclerosis. The traditional Chinese medicine is prepared from the following raw materials in parts by weight: 50-70 parts of radix astragali, 8-12 parts of Chinese angelica, 8-12 parts of radix paeoniae rubra, 8-12 parts of earthworm, 8-12 parts of rhizoma ligustici chuanxiong, 5-7 parts of flos carthami, 8-12 parts of peach kernel, 8-12 parts of rhizoma pinellinae praeparata and 8-12 parts of fructus aurantii. The traditional Chinese medicine provided by the invention combines multiple medicines to strengthen qi and enable blood to move and dispel stasis and dredge vessels, thereby realizing an effect of treating atherosclerosis.
Description
Technical field
The present invention relates to a kind of atherosclerotic medicine for the treatment of, being specifically related to a kind of is the atherosclerotic Chinese medicine composition for the treatment of that feedstock production forms with the Chinese herbal medicine.
Background technology
Trend, serious harm human health that rising year by year and rejuvenation are arranged based on the incidence rate of the ischemic cardio cerebrovascular diseases of atherosclerosis at present become the focus of medical circle and social concerns, and atherosclerotic control is also come into one's own day by day.
Atherosclerotic Drug therapy generally there is Western medicine, Chinese medicine and Chinese medicine and western medicine are united the three kinds of schemes of using, western medicine generally forms medicine etc. with thrombolytic medicine, Pimobendane, antagonist class medicine or inhibition angiotensin, these medicine general actions are rapid, take a moment and just can control the state of an illness, in a single day but these medicines are generally cured the symptoms, not the disease, and often just take and need take all the life, if drug withdrawal often causes recovery even the bounce-back of disease.Chinese medicine is having certain advantage aspect the treatment atherosclerosis, toxic and side effects is little and generally do not have a withdrawal reaction, but there is therapeutic effect tangible outstanding problem inadequately but treat atherosclerotic Chinese medicine now, rarely has the Chinese medicine of determined curative effect in the existing Chinese medicine.
Summary of the invention
In order to solve the problems of the technologies described above, the invention provides a kind of atherosclerotic Chinese medicine composition for the treatment of of determined curative effect.
Technical scheme of the present invention is as follows:
A kind ofly treat atherosclerotic Chinese medicine composition, be prepared from by the crude drug of following weight portion:
Radix Astragali 50-70, Radix Angelicae Sinensis 8-12, Radix Paeoniae Rubra 8-12, Pheretima 8-12, Rhizoma Chuanxiong 8-12, Flos Carthami 5-7, Semen Persicae 8-12, Rhizoma Pinelliae Preparatum 8-12, Fructus Aurantii 8-12.
The present invention adopts and is prepared as follows method: get above 10 flavors, the decocting that adds 8 times, 6 times amounts by weight boils twice, and each 1 hour, filter, concentrate, standby.
This Chinese medicine composition can also use the modern pharmaceutical technology, adopts other preparation method preparations, and can add the adjuvant that pharmaceutically allows, and is prepared into other dosage form, as tablet, and capsule, pill and sustained-release preparation etc.
In the atherosclerotic compositions for the treatment of provided by the invention, the Radix Astragali has the vigour of big tonifying the spleen and stomach, and it is capable to make gas be enough to urge blood, blood stasis dispelling and just not hindering, and help the power of all medicines, and be monarch drug, be equipped with Radix Angelicae Sinensis, blood stasis dispelling and invigorating blood circulation, be to be ministerial drug, be equipped with Radix Paeoniae Rubra, Pheretima, Rhizoma Chuanxiong, Flos Carthami and invigorate blood circulation the Pheretima dredge the meridian passage to help Radix Angelicae Sinensis, Rhizoma Pinelliae Preparatum, Fructus Aurantii dissipating phlegm and resolving masses are to be adjuvant.All medicines share in the side, make the prosperous blood of gas capable, the beniol of dispelling that becomes silted up, thus reach the atherosclerotic effect for the treatment of.
Clinical data
Fetch institute and be diagnosed as atherosclerotic patient's 200 examples, male's 134 examples wherein, women's 66 examples, the age is 30-80 year, does not have other serious diseases.
Criterion of therapeutical effect
1, produce effects: body constitution strengthens, and nervous, cardiopalmus, gas are tight, heart beating is overrun, numb limbs and tense tendons, and myocardial ischemia, it is not good enough to sleep etc., and symptom is obviously alleviated;
2, effective: body constitution strengthens, and nervous, cardiopalmus, gas are tight, and symptoms such as numbness are alleviated to some extent;
3, invalid: the basic no change of symptom.
Instructions of taking: every weight portion is potion, and one day potion is taken sooner or later.3 months is a course for the treatment of.Withdraw other drug and nutriment during this time.
Take medicine of the present invention after course for the treatment of, produce effects 112 examples among the 200 routine patients of clinical trial, effective 71 examples, invalid 17 examples, total effective rate is 91.5%, has statistical significance.
The specific embodiment
The present invention is described further below in conjunction with specific embodiment.
Embodiment 1
Get Radix Astragali 50g, Radix Angelicae Sinensis 8g, Radix Paeoniae Rubra 8g, Pheretima 8g, Rhizoma Chuanxiong 8g, Flos Carthami 5g, Semen Persicae 8g, Rhizoma Pinelliae Preparatum 8g, Fructus Aurantii 8g, the decocting that adds 8 times, 6 times amounts boils twice, and each 1 hour, filter, concentrate, standby.
Embodiment 2
Get Radix Astragali 70g, Radix Angelicae Sinensis 12g, Radix Paeoniae Rubra 12g, Pheretima 12g, Rhizoma Chuanxiong 12g, Flos Carthami 7g, Semen Persicae 12g, Rhizoma Pinelliae Preparatum 12g, Fructus Aurantii 12g, the decocting that adds 8 times, 6 times amounts boils twice, and each 1 hour, filter, concentrate, standby.
Embodiment 3
Get Radix Astragali 60g, Radix Angelicae Sinensis 10g, Radix Paeoniae Rubra 10g, Pheretima 10g, Rhizoma Chuanxiong 10g, Flos Carthami 6g, Semen Persicae 10g, Rhizoma Pinelliae Preparatum 10g, Fructus Aurantii 10g, the decocting that adds 8 times, 6 times amounts boils twice, and each 1 hour, filter, concentrate, standby.
Claims (1)
1. treat atherosclerotic Chinese medicine composition for one kind, it is characterized in that, be prepared from by the crude drug of following weight portion: Radix Astragali 50-70, Radix Angelicae Sinensis 8-12, Radix Paeoniae Rubra 8-12, Pheretima 8-12, Rhizoma Chuanxiong 8-12, Flos Carthami 5-7, Semen Persicae 8-12, Rhizoma Pinelliae Preparatum 8-12, Fructus Aurantii 8-12.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210175181 CN102670893B (en) | 2012-05-31 | 2012-05-31 | Traditional Chinese medicine composition for treating atherosclerosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210175181 CN102670893B (en) | 2012-05-31 | 2012-05-31 | Traditional Chinese medicine composition for treating atherosclerosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102670893A CN102670893A (en) | 2012-09-19 |
| CN102670893B true CN102670893B (en) | 2013-07-03 |
Family
ID=46803878
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201210175181 Active CN102670893B (en) | 2012-05-31 | 2012-05-31 | Traditional Chinese medicine composition for treating atherosclerosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102670893B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103285275A (en) * | 2013-06-18 | 2013-09-11 | 冯宇伟 | Medicament for preventing and treating atherosclerosis and preparation method thereof |
| CN107669910B (en) * | 2017-09-26 | 2020-10-30 | 银川市中医医院 | Pharmaceutical composition for treating atherosclerosis |
| CN112494581A (en) * | 2020-12-08 | 2021-03-16 | 河南中医药大学 | Anti-atherosclerosis traditional Chinese medicine compound preparation, preparation method and production device thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100502904C (en) * | 2006-04-11 | 2009-06-24 | 广西玉林方特药业有限责任公司 | Qixue Tongluo drug and preparation method thereof |
-
2012
- 2012-05-31 CN CN 201210175181 patent/CN102670893B/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN102670893A (en) | 2012-09-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101919988A (en) | Medicine compound for curing rheumatism rheumatoid arthritis and preparation method thereof | |
| CN102058784A (en) | Medicinal composition for treating pulmonary heart disease and application thereof | |
| CN102670893B (en) | Traditional Chinese medicine composition for treating atherosclerosis | |
| CN104043050A (en) | Traditional Chinese medicine composition for treating cholecystitis | |
| CN100358573C (en) | Medicine composition for treating gastritis, and its prepn. method | |
| CN102552512B (en) | Traditional Chinese medicine used for treating hepatitis B | |
| CN105012735B (en) | One kind fills blood anticancer traditional Chinese medicinal composition | |
| CN104547633B (en) | A kind of Chinese medicine composition for treating cervical spondylopathy and preparation method thereof | |
| CN103041145B (en) | Traditional Chinese medicine composition for treating exogenous fever | |
| CN102335311B (en) | Decoction for treating intestinal obstruction, and application thereof | |
| CN102824551B (en) | Traditional Chinese medicine for treating Raynaud disease and processing technology for traditional Chinese medicine | |
| CN103446350A (en) | Traditional Chinese medicine for treating chronic appendicitis | |
| CN104857188A (en) | Traditional Chinese medicine composite for treating edema | |
| CN100998733A (en) | Oral traditional Chinese medicine for treating trigeminal neuralgia of prolonged illness entering subsidiary channels type | |
| CN103393909B (en) | Chinese medicinal preparation for treating biliary calculus with cholecystitis | |
| CN102266451A (en) | Medicament for treating infantile eczema and preparation method thereof | |
| CN102727773B (en) | Traditional Chinese medicinal capsule for treating blood mucoviscidosis | |
| CN102283981A (en) | Drug for curing hyperthyroidism and preparation method thereof | |
| CN102293943A (en) | Medicinal liquor for treating rheumatism and preparation method | |
| CN101502597B (en) | Medicament for treating stomachache and preparation method thereof | |
| CN101199619B (en) | Oral administration Chinese medicine for treating chronic conjunctivitis | |
| CN101732470A (en) | Medicinal composition for treating protrusion of lumbar vertebral disc and osteonecrosis of femeral head and usage thereof | |
| CN103585517A (en) | Drug composition for treating hepatitis and cholecystitis and preparation method thereof | |
| CN104001026A (en) | Medicine for treating myocardial ischemia | |
| CN104000871A (en) | Drug for treating myocardial ischemia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C53 | Correction of patent for invention or patent application | ||
| CB02 | Change of applicant information |
Address after: 250014 A611, Qi Qi building, No. ten, No. 14717, Lixia Road, Lixia District, Shandong, Ji'nan Applicant after: Liu Danan Address before: 550004, 28 medical street, Yunyan District, Guizhou, Guiyang Applicant before: Liu Danan |
|
| C53 | Correction of patent for invention or patent application | ||
| CB02 | Change of applicant information |
Address after: 550004, No. 5, building 6, building A, Xinhua garden, 19 Beijing Road, Guizhou, Guiyang Applicant after: Liu Danan Address before: 250014 A611, Qi Qi building, No. ten, No. 14717, Lixia Road, Lixia District, Shandong, Ji'nan Applicant before: Liu Danan |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: RUDONG TECHNOLOGY CENTER Free format text: FORMER OWNER: LIU DANAN Effective date: 20131204 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 550004 GUIYANG, GUIZHOU PROVINCE TO: 226400 NANTONG, JIANGSU PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20131204 Address after: 226400 No. 66 Youyi West Road, dug Town, Rudong County, Jiangsu, Nantong Patentee after: Rudong science and Technology Center Address before: 550004, No. 5, building 6, building A, Xinhua garden, 19 Beijing Road, Guizhou, Guiyang Patentee before: Liu Danan |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20200630 Address after: No. 10, Fandi South Road, juegang Town, Rudong County, Nantong City, Jiangsu Province Patentee after: Rudong industrial and commercial information consulting service center Address before: 226400 No. 66 Youyi West Road, dug Town, Rudong County, Jiangsu, Nantong Patentee before: Rudong science and Technology Center |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20210827 Address after: 226400 No.8, wisdom Avenue, Donghu scenic area, Dayu Town, Rudong County, Nantong City, Jiangsu Province Patentee after: Nantong Donghu International Travel Agency Co., Ltd Address before: 226400 No.10 Fandi South Road, juegang Town, Rudong County, Nantong City, Jiangsu Province Patentee before: Rudong industrial and commercial information consulting service center |
|
| TR01 | Transfer of patent right |